Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
Price:
63.8
CNY
3.32%
Market Cap:
¥4.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
|
CN |
|
M
|
Mahalaxmi Rubtech Ltd
NSE:MHLXMIRU
|
IN |
|
EPCO Co Ltd
TSE:2311
|
JP |
|
M
|
Meta Health Ltd
SGX:5DX
|
SG |
|
L
|
Lien Chang Electronic Enterprise Co Ltd
TWSE:2431
|
TW |
|
YEDIGITALCorporation
TSE:2354
|
JP |
|
C
|
Cpi Fim SA
WSE:OPG
|
LU |
|
Q
|
Quantum Thinking Ltd
HKEX:8050
|
HK |
|
C
|
CNFinance Holdings Ltd
NYSE:CNF
|
CN |
Cash Flow Statement
Cash Flow Statement
Medprin Regenerative Medical Technologies Co Ltd
Medprin Regenerative Medical Technologies Co Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Cash Taxes Paid |
(8)
|
(9)
|
(12)
|
(10)
|
(4)
|
(2)
|
0
|
(0)
|
(7)
|
(9)
|
(15)
|
(16)
|
(19)
|
(25)
|
(30)
|
(34)
|
(39)
|
(43)
|
(43)
|
(45)
|
|
| Change in Working Capital |
(70)
|
(75)
|
(75)
|
(82)
|
(81)
|
(94)
|
(109)
|
(118)
|
(126)
|
(114)
|
(109)
|
(87)
|
(93)
|
(101)
|
(106)
|
(125)
|
(100)
|
(97)
|
(117)
|
(131)
|
|
| Cash from Operating Activities |
34
N/A
|
46
+37%
|
48
+4%
|
56
+15%
|
67
+19%
|
58
-12%
|
64
+10%
|
66
+3%
|
48
-27%
|
70
+45%
|
67
-5%
|
89
+33%
|
108
+22%
|
104
-3%
|
105
+1%
|
100
-5%
|
116
+17%
|
130
+11%
|
139
+7%
|
137
-1%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(62)
|
(84)
|
(96)
|
(132)
|
(153)
|
(162)
|
(169)
|
(146)
|
(136)
|
(100)
|
(74)
|
(68)
|
(40)
|
(44)
|
(47)
|
(35)
|
(33)
|
(27)
|
(20)
|
(25)
|
|
| Other Items |
(30)
|
(23)
|
(18)
|
(171)
|
(162)
|
(130)
|
(79)
|
71
|
155
|
93
|
49
|
51
|
(42)
|
3
|
51
|
21
|
25
|
(56)
|
(88)
|
(82)
|
|
| Cash from Investing Activities |
(92)
N/A
|
(107)
-17%
|
(114)
-6%
|
(303)
-166%
|
(315)
-4%
|
(292)
+7%
|
(248)
+15%
|
(75)
+70%
|
19
N/A
|
(7)
N/A
|
(25)
-242%
|
(17)
+33%
|
(82)
-388%
|
(40)
+51%
|
5
N/A
|
(14)
N/A
|
(8)
+39%
|
(83)
-896%
|
(108)
-31%
|
(108)
+1%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Debt |
47
|
69
|
80
|
77
|
54
|
0
|
0
|
0
|
(25)
|
(50)
|
(50)
|
(50)
|
(27)
|
0
|
(52)
|
(52)
|
(50)
|
0
|
0
|
0
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(7)
|
(8)
|
(9)
|
(16)
|
(15)
|
(15)
|
(15)
|
(28)
|
(27)
|
(27)
|
0
|
(41)
|
(41)
|
|
| Other |
(6)
|
(7)
|
(7)
|
192
|
193
|
193
|
193
|
(6)
|
(3)
|
(2)
|
(2)
|
2
|
(2)
|
(11)
|
(13)
|
(4)
|
(4)
|
5
|
8
|
11
|
|
| Cash from Financing Activities |
41
N/A
|
62
+50%
|
72
+16%
|
269
+272%
|
247
-8%
|
226
-9%
|
196
-13%
|
(13)
N/A
|
(35)
-162%
|
(61)
-73%
|
(68)
-11%
|
(64)
+6%
|
(44)
+31%
|
(27)
+38%
|
(93)
-239%
|
(83)
+10%
|
(82)
+2%
|
(72)
+12%
|
(33)
+54%
|
(29)
+12%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
3
|
3
|
3
|
3
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
|
| Net Change in Cash |
(17)
N/A
|
1
N/A
|
6
+620%
|
21
+246%
|
(1)
N/A
|
(8)
-491%
|
12
N/A
|
(22)
N/A
|
35
N/A
|
5
-86%
|
(23)
N/A
|
10
N/A
|
(18)
N/A
|
37
N/A
|
17
-52%
|
3
-83%
|
27
+799%
|
(25)
N/A
|
(3)
+90%
|
0
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(28)
N/A
|
(38)
-36%
|
(47)
-25%
|
(76)
-61%
|
(86)
-13%
|
(103)
-20%
|
(105)
-1%
|
(80)
+24%
|
(88)
-10%
|
(30)
+66%
|
(8)
+74%
|
20
N/A
|
68
+230%
|
60
-11%
|
59
-3%
|
65
+10%
|
83
+29%
|
102
+23%
|
118
+15%
|
111
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
